Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Viracta Therapeutics, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Viracta Therapeutics, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Viracta Therapeutics, Inc..